Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04141085 · ClinicalTrials.gov registry record

Transcriptomic Evaluation of Endometrial Receptivity

A clinical trial, sponsored by Reproductive Medicine Associates of New Jersey.

Completed
Registry status
63
Enrollment target

NCT04141085 is a clinical trial that has completed, run by Reproductive Medicine Associates of New Jersey. The registered enrollment target is 63 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04141085 has completed, sponsored by Reproductive Medicine Associates of New Jersey.

COMPLETED
Registry status
63 participants
Enrollment target

Study Summary

The purpose of this study is to comprehensively evaluate the transcriptomic signal of the endometrium before, during, and after the window of receptivity.

Interventions

  • OTHER Endometrial biopsy

Trial Details

FieldValue
Enrollment Target 63 participants
Start Date 2020-01-28
Est. Completion 2022-12-15

What the Registry Record Tells You About NCT04141085

The ClinicalTrials.gov registry entry for NCT04141085 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 63 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Reproductive Medicine Associates of New Jersey, which has 51 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Endometrial biopsy is the first listed.

NCT04141085 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04141085 about?

NCT04141085 is a clinical study titled "Transcriptomic Evaluation of Endometrial Receptivity". The purpose of this study is to comprehensively evaluate the transcriptomic signal of the endometrium before, during, and after the window of receptivity.

What is the current status of trial NCT04141085?

This trial is currently completed. The enrollment target is 63 participants. The study started on 2020-01-28. Estimated completion is 2022-12-15.

What interventions are being tested in trial NCT04141085?

The interventions under investigation include: Endometrial biopsy (OTHER).

Who is sponsoring clinical trial NCT04141085?

This trial is sponsored by Reproductive Medicine Associates of New Jersey, which has 51 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.